Trade Vericel Corp - VCEL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.19 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024262% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00204% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 56.91 |
| Open | 56.2 |
| 1-Year Change | 64.86% |
| Day's Range | 55.88 - 57.4 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 12, 2024 | 56.91 | -0.84 | -1.45% | 57.75 | 58.70 | 56.76 |
| Dec 11, 2024 | 57.86 | 0.11 | 0.19% | 57.75 | 59.81 | 57.75 |
| Dec 10, 2024 | 57.52 | 1.21 | 2.15% | 56.31 | 58.62 | 55.47 |
| Dec 9, 2024 | 56.21 | -0.18 | -0.32% | 56.39 | 56.92 | 55.16 |
| Dec 6, 2024 | 56.25 | -0.10 | -0.18% | 56.35 | 56.93 | 55.37 |
| Dec 5, 2024 | 56.40 | -1.14 | -1.98% | 57.54 | 58.31 | 56.29 |
| Dec 4, 2024 | 58.09 | 0.36 | 0.62% | 57.73 | 59.70 | 56.99 |
| Dec 3, 2024 | 58.15 | -0.45 | -0.77% | 58.60 | 59.23 | 56.81 |
| Dec 2, 2024 | 58.65 | 1.58 | 2.77% | 57.07 | 59.28 | 57.07 |
| Nov 29, 2024 | 57.97 | 0.26 | 0.45% | 57.71 | 58.39 | 57.30 |
| Nov 27, 2024 | 57.65 | -1.06 | -1.81% | 58.71 | 59.05 | 57.20 |
| Nov 26, 2024 | 58.69 | 0.71 | 1.22% | 57.98 | 58.71 | 55.95 |
| Nov 25, 2024 | 58.52 | -1.03 | -1.73% | 59.55 | 60.97 | 58.20 |
| Nov 22, 2024 | 58.97 | 2.52 | 4.46% | 56.45 | 60.03 | 55.86 |
| Nov 21, 2024 | 56.57 | -0.64 | -1.12% | 57.21 | 58.40 | 56.11 |
| Nov 20, 2024 | 57.17 | 1.39 | 2.49% | 55.78 | 57.21 | 55.27 |
| Nov 19, 2024 | 55.74 | 3.43 | 6.56% | 52.31 | 56.05 | 52.14 |
| Nov 18, 2024 | 52.85 | 0.67 | 1.28% | 52.18 | 53.70 | 51.48 |
| Nov 15, 2024 | 52.39 | -0.07 | -0.13% | 52.46 | 53.21 | 51.74 |
| Nov 14, 2024 | 52.69 | -1.78 | -3.27% | 54.47 | 55.41 | 52.46 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Vericel Corp Ord Company profile
About Vericel Corp
Vericel Corporation is a commercial-stage biopharmaceutical company. The Company specializes in cell therapies and specialty biologics for the sports medicine and severe burn care. It operates in one reportable segment, the research, product development, manufacture, and distribution of cellular therapies for use in the treatment of specific diseases. It markets two autologous cell therapy products in the United States, which includes MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The MACI is an autologous cellularized scaffold product indicated for the repair of symptomatic, single, or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. The Epicel is a permanent skin replacement humanitarian use device (HUD) for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area (TBSA).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Vericel Corp revenues increased 26% to $156.2M. Net loss totaled $7.5M vs. income of $2.9M. Revenues reflect MACI segment increase of 18% to $111.6M, Epicel segment increase of 51% to $41.5M. Net loss reflects Stock-based Compensation in SGA increase from $10M to $26.5M (expense), Other Selling , General Expense increase of 21% to $71.1M (expense).
Equity composition
Common Stock no Par, 3/11, 62.5M auth., 38,618,037 issd. Insiders control approx. 0.63%. IPO: 2/97, 3M shares @ $7 byCowen & Company. 02/10 1-for-8 reverse split. 10/13, 1-for-20 Reverse Stock split.
| Industry: | Biopharmaceuticals |
64 Sidney St
CAMBRIDGE
MASSACHUSETTS 02139-4170
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com